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Use explicit headers/labeling
• use headers that help readers find your main 
points & key information.  In other words, the 
section header can emphasize the message not 
the category
• consider stating the take-home message in the 
large section headings
• example: instead of saying “Imaging” or “MRI of 
brain,” say “Prompt recognition and treatment 
resulted in complete neurologic recovery.”
Objective
Outline the clinical course of a patient with mast cell 
gastroenteritis and describe typical presentation, 
interpretation of results, and suggested treatments for 
this evolving diagnosis. 
History of Presenting Illness
38 y/o woman with hx of RA and MCTD, has 
several recent hospitalizations for colitis/enteritis of 
unknown etiology. 
Current constellation of symptoms:
• 4 days of nausea and intractable vomiting 
• new-onset rectal fullness with constipation for 4 days
• mucoid rectal discharge for 2 days
Symptoms that started 3 months ago:
• Intermittent intractable vomiting, diarrhea, and 
abdominal pain
• Complete resolution of symptoms in between 
episodes
• 3 different admissions at 3 different hospitals
Social History
Negative for drug use including marijuana. Travel 
history includes frequent travel for long periods of time 
to Mexico to visit family.
Physical Exam
Patient had mild tachycardia but had an otherwise 
benign exam including a normal rectal. Clear mucoid 
discharge was seen on her bed sheets.
Workup prior to admission
• Positive lactoferrin
• QuantiFERON Gold TB screen positive
• CT scan showing inflammatory small and large bowel 
patterns consistent with inflammatory bowel disease
• Upper and lower endoscopy with biopsies—
inconclusive studies without signs of inflammation
• Exploratory laparoscopy within normal limits
• Serum inflammatory markers inconclusive
Workup during admission
• Normal CBC with diff
• 2+ protein and 3+ blood on UA
• ESR 10 and CRP 2.4
• Compliment C3/C4 low, with normal C1 esterase
• Repeat abdominal imaging showed diffuse small 
bowel and colon inflammatory wall thickening with 
severe rectal wall thickening.
• Flexible sigmoidoscopy showed significantly 
congested rectal mucosa and a patch of mildly 
erythematous mucosa
• Rheumatologic workup negative for acute flare
• Mixed connective tissue disease confirmed with no 
new findings
Radiographic Imaging
Direct Imaging
Severe rectal wall thickening (see arrow) seen in 
the setting of constipation on admission. Similar 
changes observed in more proximal segments of 
the colon in previous images
In hopes of discovering a cause for the patient’s 
symptoms, empiric treatments were held off for almost 
a week.
• Colitis ruled out on endoscopy and biopsies 
• Vasculitis was ruled out due to symptoms being 
localized to GI system only and no signs of vasculitis 
seen on rectal biopsy 
• Proteinuria and hematuria found to be secondary to 
menstruation and not part of a vasculitis
• No signs of serositis or rheumatologic flare found 
• Underlying mixed connective tissue disease 
confirmed on rheumatologic workup but not likely 
contributing to GI symptoms
• Hereditary angioedema unlikely with normal C1 
esterase
Sigmoidoscopy biopsies tested post hoc for eosinophilic 
and mast cell gastroenteritis. 
• No eosinophilic infiltration was seen
• A total of 26 CD117+ mast cells per hpf were 
described in lamina propria 
• No evidence of systemic mastocytosis during 
admission suggesting an intraluminal cause of 
observed pathology
Discussion
• Rectal hydrocortisone quickly helped to relieve 
constipation and mucosal discharge
• Empiric high-dose IV methylprednisolone for 48-36 
hours
• Initiation of PO budesonide once tolerating oral 
intake
• Mast cells in the GI tract can cause intractable 
vomiting and diffuse small and large bowel 
inflammation, as demonstrated in this case1,2
• Activation of mast cells may be the primary cause of 
GI pathology, or secondary to another process3
• Within the lamina propria mast cells are stained with 
CD117 and found with an average of 13 cells/hpf4
• No specific criteria exists at this time for mast cell 
gastroenteritis (MCG), but one study suggests a 
cutoff of 20 cells/hpf within the lamina propria4
• Most commonly proposed cause of MCG is food 
allergen4
• Treatments suggested for GI mast cell activation 
include H2 antihistamines, cromolyn, antileukotriene
drugs, and budesonide1,4
Image 1-CT Abdomen/Pelvis
Image 2-Flexible Sigmoidoscopy
Image 3-CD117 Stain
Multifocal small bowel thickening demonstrated 
in patient’s abdominal imaging. At the current 
level two foci of thickening can be seen (see 
arrows).
Direct visualization of the rectum shows no signs 
of inflammation. Other than nonspecific swelling 
no other findings were found on sigmoidoscopy.
Example of a positive CD117 stain for 
mast cells. Testing is done on a biopsy of 
the gastrointestinal tissues and cells are 
seen within the lamina propria. 
Differential Diagnosis
• Inflammatory bowel disease
• Irritable bowel disease
• Small vessel vasculitis
• Hereditary angioedema
• Acute intermittent porphyria
• Eosinophilic gastroenteritis
• Intra-abdominal TB
Treatment Pathway
I II
IVIII
Figure 1-Mast Cell Inhibitors
I. U inhibited mast cell degranulation
II. Decrease  mast cell recruitm nt due to 
dampened immunologic response from 
steroids6
III. Mast cell stabilizers prevent release of 
granules
IV. Inhibition of mast cell mediators after 
degranulation
Image courtesy of Graham et al.
Steroids
Cromolyn
Ketotifen
Quercetin
Histamine antagonists like 
H2 blockers
Protease antagonists
Leukotriene antagonists like 
montelukast
Image courtesy of Ramsay et al.
